Who is sponsoring NCT03048968?

NCT03048968 is sponsored by Samsung Medical Center.

What drugs are being tested in NCT03048968?

Interventions in NCT03048968: Gait, sit-to-stand movement, stair climbing and treadmill gait, Sit-to-stand movement and treadmill gait, gait enhancing mechatronic system (GEMS), treadmill.

What condition does NCT03048968 study?

NCT03048968 studies Stroke, Healthy.

Is NCT03048968 still recruiting?

NCT03048968 is currently completed. Last updated 29 April 2019.

Last reviewed 2019-04-29 · How we verify

NCT03048968

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of a Walking Assist Robot on Gait Function and Brain Activity in Stroke Patients and Elderly Adults

Completed NA Last updated 29 April 2019

What this trial tests

NA trial testing Gait, sit-to-stand movement, stair climbing and treadmill gait in Stroke in 40 participants. Completed in 23 October 2017.

Timeline

1 March 2017

Primary endpoint
30 September 2017

23 October 2017

Quick facts

Lead sponsor	Samsung Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	40
Start date	1 March 2017
Primary completion	30 September 2017
Estimated completion	23 October 2017
Sites	1 location across South Korea

Drugs / interventions tested

Gait, sit-to-stand movement, stair climbing and treadmill gait
Sit-to-stand movement and treadmill gait
gait enhancing mechatronic system (GEMS)
treadmill

Conditions studied

Stroke — all drugs for Stroke →
Healthy — all drugs for Healthy →

Sponsor

Samsung Medical Center

Who can join

Adults 20 to 84, any sex, with Stroke or Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to investigate the effects of the new wearable hip assist robot, gait enhancing and motivating system (GEMS) developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) on gait, sit-to-stand movement and cortical activation in elderly adults and stroke patients.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Wearable hip-assist robot modulates cortical activation during gait in stroke patients: a functional near-infrared spectroscopy study.
Lee SH, Lee HJ, Shim Y, Chang WH, et al · · 2020 · cited 25× · PMID 33121535 · DOI 10.1186/s12984-020-00777-0
Wearable Hip-assist Robot Modulates Cortical Activation during Gait in Stroke Patients: A Functional Near-Infrared Spectroscopy Study
Lee S, Lee H, Shim Y, Chang WH, et al · · 2020 · DOI 10.21203/rs.3.rs-23523/v2
European Stroke Organisation Conference: Abstracts
· 2018

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other Samsung Medical Center trials

Trials by the same sponsor.

NCT07482865 — Routine Versus Provisional Distal Perfusion Catheter Placement in Patients Undergoing Mechanical Circulatory Support · NA · not yet recruiting
NCT07467213 — Routine Use of Potassium Competitive Acid Blocker vs. Guideline-Directed Gastrointestinal Protection Strategy in Acute M · Phase 4 · not yet recruiting
NCT07530913 — Effectiveness Analysis of a Rehabilitation Exercise Platform for Living Donor Liver Transplantation Patients · NA · enrolling by invitation
NCT07500701 — Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Pro · Phase 3 · recruiting
NCT07409441 — Korea Acute Myocardial Infarction Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03048968 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Samsung Medical Center
Last refreshed: 29 April 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03048968.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing